Peptide Surge Fuels Unregulated “Gray Market” Products
Public interest in injectable peptides has surged in recent years, driven in part by the popularity of GLP-1 receptor agonists such as Ozempic. More recently, interest has extended to a broader range of peptide compounds marketed for purposes like muscle growth, recovery, anti-aging and the management of various health conditions. This has given rise to […]
Elevated Levels of Toxicants Found in Teeth of Autistic Children
A pilot study from the University of Texas San Antonio (UTSA) Health Center adds to existing bodies of evidence that link exposure to toxicants such as pesticides, flame retardants and plastics with neurotoxicity and autism. Researchers found that the primary teeth of children with autism had elevated levels of toxicants compared to the primary teeth […]
NIH to Launch Research Center on Vaccine Injuries
The U.S. National Institutes of Health (NIH) will launch a clinical research program and dedicated center to study individuals who were harmed by vaccines, including COVID-19 shots. Officials at the National Institute of Allergy and Infectious Diseases (NIAID) discussed establishing the research center at the NIH campus in Bethesda, Maryland, with the program potentially beginning […]
Moderna/Merck Personalized mRNA Melanoma Cancer Shot Uses AI-Generated Design
A personalized mRNA melanoma cancer shot developed by Moderna and Merck using an AI generated design has met the primary endpoint in a late-stage phase 3 clinical trial.1 In August, the two pharmaceutical giants reported that, when combined with an existing treatment, the vaccine reduced the risk of melanoma returning or spreading. Cancer experts are enthusiastic […]
6G Technology Will Expose People to Untested Electromagnetic Fields
A new wireless 6G internet network is set to deploy globally by the year 2030 to succeed the current 5G. The 6G lead up is promising faster internet speed, convergence of wireless networks with artificial intelligence, and joint communications or “sensing, ”which allows the network’s ability to “infer“ the presence of objects and people.1 But […]
European Medicines Agency Begins Review of New Lyme Disease Vaccine
European Union (E.U.) officials will begin the study and review process for Pfizer and Valneva’s vaccine targeting Lyme disease, the world’s most common tick-borne illness. There is currently no commercially approved Lyme disease vaccine.1 2 Pfizer, along with French-Swiss pharmaceutical company Valneva say trials have shown 70 percent efficacy in people ages five and older […]